BioLineRx Ltd. (BLRX)
2.80
-0.01
(-0.36%)
USD |
NASDAQ |
Aug 24, 16:00
2.80
0.00 (0.00%)
After-Hours: 20:00
BioLineRx Shareholders Equity (Quarterly) : 16.67M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 16.67M |
| December 31, 2025 | 18.20M |
| September 30, 2025 | 19.53M |
| June 30, 2025 | 20.07M |
| March 31, 2025 | 20.86M |
| December 31, 2024 | 13.46M |
| September 30, 2024 | 8.505M |
| June 30, 2024 | 13.98M |
| March 31, 2024 | 13.06M |
| December 31, 2023 | 13.22M |
| September 30, 2023 | 13.13M |
| June 30, 2023 | 21.05M |
| March 31, 2023 | 39.11M |
| December 31, 2022 | 50.84M |
| September 30, 2022 | 55.52M |
| June 30, 2022 | 56.57M |
| March 31, 2022 | 63.41M |
| December 31, 2021 | 68.09M |
| September 30, 2021 | 70.90M |
| June 30, 2021 | 73.89M |
| March 31, 2021 | 64.65M |
| December 31, 2020 | 22.03M |
| September 30, 2020 | 24.81M |
| June 30, 2020 | 29.23M |
| March 31, 2020 | 28.51M |
| Date | Value |
|---|---|
| December 31, 2019 | 33.38M |
| September 30, 2019 | 39.20M |
| June 30, 2019 | 41.78M |
| March 31, 2019 | 45.89M |
| December 31, 2018 | 41.32M |
| September 30, 2018 | 40.58M |
| June 30, 2018 | 46.19M |
| March 31, 2018 | 49.02M |
| December 31, 2017 | 52.88M |
| September 30, 2017 | 58.96M |
| June 30, 2017 | 57.38M |
| March 31, 2017 | 35.63M |
| December 31, 2016 | 34.99M |
| September 30, 2016 | 38.62M |
| June 30, 2016 | 42.56M |
| March 31, 2016 | 46.00M |
| December 31, 2015 | 47.61M |
| September 30, 2015 | 50.67M |
| June 30, 2015 | 51.82M |
| March 31, 2015 | 54.19M |
| December 31, 2014 | 31.79M |
| September 30, 2014 | 26.87M |
| June 30, 2014 | 29.32M |
| March 31, 2014 | 32.34M |
| December 31, 2013 | 11.72M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 269.56M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 13.95M |
| Revium Recovery, Inc. | 18.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 38.80M |
| Total Liabilities (Quarterly) | 17.96M |
| Debt to Equity Ratio | 0.544 |
| Current Ratio | 1.584 |
| Net Debt Paydown Yield | 11.93% |